Published: 24-08-2022 13:44 | Updated: 24-08-2022 13:46

Current calls, week 34, 2022

Tips from KI Grants Office about current calls

Swedish and Nordic calls

Selma Andersons stipendiestiftelse

Ett eller flera stipendier utdelas av rektor vid Uppsala universitet enligt följande:

1. Till kvinna, som vid något av rikets universitet eller högskolor avlagt doktorsexamen och i samband därmed visat verklig vetenskaplig begåvning, som understöd för vetenskaplig undersökning, studieresa eller utgivande av vetenskapligt arbete.

2. Till kvinna, vilken vid någon av ovannämnda läroanstalter är antagen till forskarutbildningen och visat verklig vetenskaplig begåvning, som understöd för arbete med doktorsavhandling.

Closing date: 7 September 2022

Further information

Medicinska fakultetens i Uppsala stiftelse för psykiatrisk och neurologisk forskning

Att främja vetenskaplig forskning inom psykiatri och neurologi främst beträffande de s.k. funktionella nervsjukdomarna. Skall tilldelas vetenskapsidkare, som genom arbete eller forskning i psykiatri eller neurologi gjort sig förtjänt därav och som är svensk medborgare.

Closing date: 7 September 2022

Further information

International post doc within medicine and health - Swedish Research Council

Supports research in the field of medicine and health and enables researchers to expand their networks and competencies by working abroad under secure employment conditions. Grants are worth SEK 1.15 million per year for between 18 months and three years.

Closing date: 13 September 2022

Further information

International postdoc within natural and engineering sciences - Swedish Research Council

Enables researchers in the field of natural and engineering sciences to expand their networks and their competences by working abroad under secure employment conditions. Grants are worth SEK 1.2 million per year between 18 months and three years.

Closing date: 13 September 2022

Further information

International postdoc grant within the humanities and social sciences, including educational sciences - Swedish Research Council

Enables early-career researchers within humanities and social sciences including educational sciences to work at a host university or research institution abroad in order to expand their network and competencies. The grant is worth SEK 1.15 million per year for 18 to 36 months.

Closing date: 13 September 2022

Further information

Grant for research communication in migration and integration - Swedish Research Council

Enables holders of earlier or ongoing research grants from the Swedish Research Council to plan, implement and evaluate communication activities that entail dialogue or co-creation with identified groups outside academia. Grants are worth between SEK 100,000 and SEK 500,000 for grants lasting six to 12 months and between SEK 200,000 and SEK 1 million for grants lasting 13 to 24 months.

Closing date: 20 September 2022

Further information

Wenner-Gren stiftelsernas stipendier

  • Postdoktorstipendier för utbildning i Sverige (utländska postdoktorer): Stipendierna är avsedda att möjliggöra för utländska disputerade forskare att verka vid svensk vetenskaplig institution.
  • Gästforskarstipendier: Stipendierna är avsedda att underlätta för utländska seniora forskare att verka i Sverige.
  • Sabbatsstipendier: Stipendierna är avsedda att möjliggöra för svensk senior forskare, vanligen professor, att verka vid utländsk vetenskaplig institution.
  • Resestipendier: Stipendierna är avsedda för kortare tids besök utomlands för aktivt deltagande i internationella kongresser, symposier, workshops och kurser. Medel ges inte för forskningsvistelser utomlands.

Closing date: 1 October 2022

Further information

Fellowship inom vårdforskning - Cancerfonden

Anslaget är en extrasatsning från Cancerfonden med syfte att främja cancerforskning inom området vårdforskning genom att ge forskare vid svenska institutioner möjlighet att under tre års tid ägna sig åt forskning inom detta område.

Closing date: 6 October 2022

Further information

European calls

COST action call - European Cooperation in Science and Technology

European Cooperation in Science and Technology (COST) invites proposals for its action call. This supports networking activities such as meetings, short-term scientific missions, training schools and dissemination activities in the areas of science and technology. The aim is to foster the scientific, technological, economic, cultural or societal knowledge advancement and development of Europe.

Projects must include a network of proposers from at least seven COST member countries or cooperating states. Half of the countries in the project group must be inclusiveness target countries, namely Albania, Bosnia-Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Luxembourg, Malta, Moldova, Montenegro, Poland, Portugal, Romania, Slovenia, Slovakia, the Republic of North Macedonia, the Republic of Serbia and Turkey. The participation of applicants from near neighbour countries is particularly encouraged, who are eligible as secondary proposers. Applicants may be researchers and innovators from different fields and horizons such as universities, research centres and companies, in particular small and medium-sized enterprises, as well as other relevant actors.

Closing date: 20 October 2022

Further information

Clinical research collaborations programme - European Respiratory Society

The European Respiratory Society invites proposals for its clinical research collaborations programme. This supports projects within respiratory medicine, to build and maintain European multi-centre networks of researchers.

Collaborative platforms may involve multiple stakeholders, such as clinical researchers and translational researchers, with representatives from other specialties, including radiologists, biostatisticians, associated funding partners, patients. Grants are worth up to €15,000 per year for up to three years.

Closing date 15 October 2022

Further information

Child development grants – diet and the microbiome and rolandic epilepsy - Waterloo Foundation, GB

The Waterloo Foundation invites applications for its child development fund – diet and the microbiome and rolandic epilepsy. This supports research projects on diet or the microbiome in child development as well as rolandic epilepsy. Studies are particularly welcomed that consider the effect of diet or the microbiome on neurodevelopmental disorders. Those that consider these areas on child psychological outcomes, such as behavioural, emotional or cognitive, are also welcomed. The foundation is also interested in the influence of prenatal factors and in a range of vitamins and minerals, including omega-3, vitamin D and iodine. For rolandic epilepsy, studies focusing on the following are particularly welcomed:

•the profile of ongoing deficits in adulthood;

•whether severity in childhood is related to adult outcomes;

•the co-occurrence of rolandic epilepsy with other neurodevelopmental disorders.

Researchers based at any university worldwide may apply, however applications from the UK may be favoured due to better cost efficiency. PIs must have a PhD. Applications that help junior researchers progress in their fields are encouraged.

Closing Date: 9 October 2022

Further information

Biomedical research project grants - Motor Neurone Disease Association, GB

The Motor Neurone Disease Association invites summary applications for its biomedical research project grants. These support research aimed at understanding the causes of motor neurone disease, elucidating disease mechanisms and facilitating the translation of therapeutic strategies from the laboratory to the clinic. Grants support single pieces of work designed to answer a single question or a small group of related questions.

Applicants can be based outside the UK and the Republic of Ireland provided the project is unique in concept or design, namely no similar research is being performed in the UK, and involves an aspect of collaboration with a UK institute. Funding is worth up to £95,000 per year for non-London institutes.

Closing Date: 28 October 2022

Further information

ECCO-IBUS intestinal ultrasound research grant - European Crohn's and Colitis Organisation

The European Crohn’s and Colitis Organisation, in collaboration with the International Bowel Ultrasound Group, invites applications for its intestinal ultrasound research grant. This supports research into the utility of intestinal ultrasounds used in the assessment of patients with inflammatory bowel disease.

Applicants must be members of IBUS at the time of application and should be established within clinical units with expertise in inflammatory bowel disease, with established expertise in the performance of intestinal ultrasound and routine access to an ultrasound machine. The grant is worth €20,000

Closing date: 31 October 2022

Further information

US calls

Federal Funding agencies

Identifying Host Cell Death Pathway Targets for Host-Directed Therapies for Treatment of Mtb and Mtb/HIV Co-Infection (R01 Clinical Trial Not Allowed): NIH

The National Institute of Allergy and Infectious Diseases invites applications for its identifying host cell death pathway targets for host-directed therapies for treatment of Mycobacterium tuberculosis  (mtb) and mtb/HIV co-infection funding opportunity. This supports mechanistic studies on host cell death pathways and their effect on immune responses to mtb and mtb/HIV co-infection to identify immune targets for development of host-directed therapies. Research projects and studies may include, but are not limited to the following topics listed below:

  • Studies aimed at basic biological mechanisms of how Mtb modulates cell death mechanisms (CDMs) to promote infection, inflammation, cell necrosis, types(s) of cell death and tissue damage.
  • Characterizing interactions between CDMs and with other cell death-associated events (e.g., DAMP release profiles) in the context of Mtb and Mtb/HIV co-infections.
  • Delineating interactions of CDMs with elements of the innate and adaptive immune systems during Mtb infection and the impact on host response effectiveness.
  • Studies that identify novel host CDMs and pathways activated during Mtb or Mtb/HIV co-infection.
  • Identification and evaluation of CDM-based targets for development of novel host-directed therapies.

The following research topics are non-responsive to this FOA and will not be reviewed:

  • Research focused on bacterial rather than host cell death mechanisms and pathways.
  • Clinical trials.

Closing date: December 7, 2022. Applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-22-223 (R01)

Further information 

Cellular and Molecular Mechanisms of Prion-Like Aggregate Seeding, Propagation, and Neurotoxicity in AD/ADRD (R01 Clinical Trial Not Allowed): NIH

The goal of this initiative is to promote studies that increase our understanding of the cellular and molecular mechanisms by which prion-like protein conversion events occur and are propagated in Alzheimer's Disease (AD) and Alzheimer's Disease Related Dementias (ADRD), as well as the downstream mechanisms that trigger neurotoxicity, pathological and circuit changes in the brain. While recent studies have focused on how prion-like misfolding of ADRD-relevant aggregates occurs at the structural level, comparatively little is known about the molecular mechanisms and cell biology that drive these events and their downstream consequences. This initiative seeks applications in areas including, but not limited to, studies designed to understand:

  • Cell biological events that occur within cells of the CNS that lead to prion-like aggregate seeding, such as aberrant post-translational processing and/or vesicular sorting.
  • How prion-like misfolding of ADRD-relevant protein aggregates is propagated between cells away from an initial seeding site, with a specific emphasis on mechanisms that involve intracellular/extracellular trafficking and/or interactions with glial cells and the brain microenvironment.
  • Cell surface receptors and signaling events activated by prion-like aggregates that drive neurodegeneration and/or cerebrovascular dysfunction in AD/ADRD.

Closing date: October 24, 2022. Applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-23-023 (R01)

Further information 

Biology of Bladder Cancer (R01 Clinical Trial Optional): NIH

While substantial progress has been made in identifying etiological factors, mutated genes and molecular profiles of bladder cancers, our mechanistic knowledge about bladder tumorigenesis and bladder cancer biology is relatively limited. Deeper knowledge of bladder cancer biology will aid our understanding in how these tumors arise and progress, identify individuals at high risk and enable the development of preventative or therapeutic interventions. Research areas of interest for this FOA include but are not limited to the following:

  • Understanding processes that mediate normal bladder development and differentiation, and how these processes relate to bladder cancer initiation and progression;
  • Understanding the role of the cancer field in bladder cancer initiation and recurrence;
  • Examining biologically focused mechanisms related to prevention of NMIBC and progression of NMIBC to MIBC, including early phase interception studies;
  • Understanding the stromal environment of the normal bladder and how these factors contribute to the microenvironment of bladder precancerous lesions, cancer or metastases;
  • Identifying functional drivers of bladder cancer, including drivers of NMIBC recurrence and the transition to invasiveness;
  • Understanding the biological nature of molecular subtypes and the mechanistic underpinnings of tumor heterogeneity;
  • Identifying biological mechanisms underlying disparities in sex, race or ethnicity in bladder cancer;
  • Mechanistic understanding of bladder cancer invasion and metastasis, including cell biological and biophysical aspects;
  • Investigating the role of the microbiome, including the urobiome, in the bladder cancer biology;
  • Understanding how alterations in carbon and energy metabolism within cells of the tumor and microenvironment affect bladder cancer biology and;
  • Development and validation of new and human-relevant models of bladder cancer, particularly ones that recapitulate the microenvironment.

All responsive applications must have all or most of the aims devoted to understanding biological aspects of bladder cancer. Projects may include an epidemiological or translational aim, including a clinical trial related to NMIBC, but this aim should complement the overall biological focus. To promote recruitment of outside investigators to the bladder cancer biology field, applicants are encouraged to include one or more co-investigators or co-principal investigators who have committed effort and expertise outside of bladder cancer that is relevant to achieving the project aims.

Closing date: October 16, 2022. Applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-22-218 (R01)

Further information


Research grant, Pfizer, US

Pfizer invites applications for its advances in migraine treatment funding opportunity. This supports projects that focus on increasing the understanding of healthcare professionals on the management and care of people with migraine. Of particular interest are educational initiatives that encompass the following:

  • unmet need and disease burden associated with migraine;
  • the role of calcitonin gene-related peptide (CGRP) in the pathophysiology of migraine;
  • anti-CGRP therapies for acute and prophylactic treatment of migraine.

It is not our intent to support clinical research projects. Projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered.

Eligibility: The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to

healthcare professional education and/or healthcare improvement.

Budget: The estimated total budget is USD 600,000. Individual grants are worth up to USD 250,000 for up to two years, although one year to 18 months project length is preferred. Indirect costs are set to a maximum of 28%.

Closing date: Full Application - 11th October 2022.

Further information 

Innovative Award, Juvenile Diabetes Research Foundation (JDRF), US

JDRF provides seed funding for highly innovative, high risk high reward research with significant potential to accelerate the mission of JDRF. Proposals should address key outstanding questions and have the potential to lead to a challenge or a change in the current paradigm or conventional wisdom and/or lead to a groundbreaking discovery. Preliminary data is not required in the proposal but the underlying concept, premise or hypothesis must be plausible and testable and the proposal must be focused with a well-defined goal that is achievable within the timeframe and amount of the award.

Eligibility: Applicants must hold an M.D., D.M.D., D.V.M., Ph.D., or equivalent degree and have a faculty position or equivalent at a college, university, medical institution, or other research facility. There are no citizenship requirements for this program.

Budget: Grants are worth USD 200,000 each direct costs for one year, which includes 10% in indirect costs.

Closing date: 13October 2022.

Further information 

Directed research grant, Pediatric Orthopaedic Society of North America, US

The Pediatric Orthopaedic Society of North America (POSNA) invites letters of intent for its directed research grant. This supports research with a profound effect on the quality or safety of the orthopaedic care of children. Grants should emphasize the following:

  • Potential applicability on a global level
  • Clear and measurable outcomes
  • Ability to successfully complete the funding proposal as measured by past experience, preliminary data and pilot work
  • Potential for expanded research, future publications and continued (extramurual) grant funding
  • Collaborative nature of the grant (number of investigators and institutions involved)

Eligibility: A member of POSNA must serve as the principal investigator.

Budget: Two grants, worth up to $50,000 each for one to two years, are available. No travel funds can be charged against the grant. No overhead, PI Salary or indirect costs can be charged against the grant.

Closing date: LOI – 12th September 2022. Full application – 12th December, 2022.

Further information 

Research grant, The Foundation for Prader-Willi Research, US

The Foundation for Prader-Willi Research invites applications for its research grants. These support innovative Prader-Willi syndrome research. Projects that will lead to new interventions to alleviate the symptoms associated with PWS are of particular interest. Priority is given to the following areas of research:

  • genotype to phenotype – understanding PWS genetics and how loss of PWS-critical region genes leads to the phenotype;
  • neurobiology of hunger and feeding behaviour in PWS;
  • neurobiology of cognitive deficits, maladaptive behaviour and mental illness in PWS;
  • clinical care research – evaluation of existing drugs and interventions to improve health and quality of life in PWS;
  • therapeutics development for PWS genetic therapies, novel pharmaceuticals or drug repurposing for PWS.

Eligibility: Academic applicants must have a primary faculty appointment at the level of instructor or higher. The grant may be particularly helpful for junior faculty in the early stages of their careers, established investigators in other areas of research who wish to enter the field of PWS research, or investigators in the PWS field who are seeking funding to support pilot studies in a new area of PWS research.

Budget: Applicants may request up to USD 150,000 in direct costs for the initial 18 months of support, with the possibility of a second term of funding upon competitive renewal. Indirect costs of up to 8% are allowed.

Deadline: LOI – 9th September 2022. Full application (by invitation) – 18th November, 2022.

Further information 1

Further information 2 

Clinical research award, The Cystic Fibrosis Foundation, US

The Cystic Fibrosis Foundation invites letters of intent for its clinical research awards. These support clinical research projects directly related to cystic fibrosis treatment and care. A number of research topics have been designated as ‘areas of encouragement’; a full list can be found in the link below.

Eligibility: Academic applicants must have a primary faculty appointment at the level of instructor or higher. The grant may be particularly helpful for junior faculty in the early stages of their careers, established investigators in other areas of research who wish to enter the field of PWS research, or investigators in the PWS field who are seeking funding to support pilot studies in a new area of PWS research.

Budget: Up to $150,000 per year (plus 12% indirect costs) for a maximum of three years may be requested for single-center clinical research awards. For multi-center clinical research, the potential award is up to $350,000 per year (plus 12% for indirect costs) for a maximum of three years. Up to an additional $100,000 over the entire project period may be available via supplemental funding.

Closing date: LOI – 16th September 2022. Full application – 2nd February, 2023.

Further informtion

The Canada Gairdner International Award

The Canada Gairdner International Award recognizes outstanding researchers whose unique scientific contributions have increased the understanding of human biology and disease and contributed to the relief of human suffering. The prize is given for transformative biomedical discovery research and is considered one of the foremost early indicators of Nobel Prize recipients.

Closing date: October 1, 2022

Further information

The John Dirks Canada Gairdner Global Health Award

The John Dirks Canada Gairdner Global Health Award recognizes the world’s leading researchers who have used rational, scientifically based research to improve the wellbeing of those facing health inequalities worldwide. While a single significant scientific discovery would continue to be sufficient evidence to select a nominee, the Award will also recognize outstanding researchers who apply rational scientific approaches to successful implementation, evaluation and policy interventions.

Gairdner invites nominations from any field of research impacting global health and health inequity.

Closing date: October 1, 2022

Further information